Furthermore, the regulatory mechanisms of endosomal abnormalities and lysosomal impairment in the pathogenesis of AD are endolysosomal protein-mediated abnormal processing mediated by endolysosomal proteins of amyloid precursor protein (APP) and impaired degradation of Aβ and hyperphosphorylated tau27,28. Here, APP is linked to Alzheimer disease.